期刊
VACCINES
卷 10, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/vaccines10111884
关键词
malaria; vaccine; axenic liver stage; subcutaneous immunization; Plasmodium yoelii
资金
- TUBITAK 1001 grant from the Scientific and Technological Research Council of Turkey [119Z409]
The study demonstrates that axenic liver stages serve as a novel live whole parasite malaria vaccine platform, providing effective protection through subcutaneous immunization without infecting the host.
Host cell-free, axenic development of liver stages (LS) of the malaria parasite has been demonstrated. Here we explored axenic liver stages as a novel live whole parasite malaria vaccine platform, which is unaltered and not prone to human-error, compared to the immunization with live-attenuated sporozoites that must be done intravenously. We show that in contrast to live sporozoites, axenic LS are not infectious to the immunized host. Subcutaneous immunizations of mice with Plasmodium yoelii axenic LS, developed from wild-type (WT) sporozoites or WT sporozoites expressing enhanced-GFP, conferred sterile protection against P. yoelii infectious sporozoite challenge. Thus, axenic liver stages of P. falciparum and P. vivax might constitute an attractive alternative to live sporozoite immunization.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据